- Home
- APMD vs RVI Comparison
APMD vs RVI Comparison
Compare APMD & RVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | APMD | RVI |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 895.5M | 778.2M |
| IPO Year | 2026 | 2025 |
Fundamental Metrics
Financial Performance| Metric | APMD | RVI |
|---|---|---|
| Price | $18.65 | $23.67 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $50.33 | N/A |
| AVG Volume (30 Days) | ★ 380.6K | 163.5K |
| Earning Date | 11-03-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $136.17 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.43 | $22.21 |
| 52 Week High | $35.29 | $77.39 |
Technical Indicators
Market Signals| Indicator | APMD | RVI |
|---|---|---|
| Relative Strength Index (RSI) | 42.47 | 32.63 |
| Support Level | $17.38 | N/A |
| Resistance Level | $20.00 | $29.72 |
| Average True Range (ATR) | 1.62 | 0.86 |
| MACD | 0.22 | -0.21 |
| Stochastic Oscillator | 41.02 | 4.87 |
Price Performance
Historical ComparisonAbout APMD Apnimed Inc. Common Stock
Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candidate, AD109, or Oxnimbi, is an investigational, fixed-dose oral combination of a novel anti-muscarinic and selective norepinephrine reuptake inhibitor for the treatment of obstructive sleep apnea (OSA).
About RVI Robinhood Ventures Fund I Common Shares of Beneficial Interest
Robinhood Ventures Fund I is a closed-end investment company. The investment objective, the Fund will mainly invest, under normal circumstances, in a concentrated portfolio generally consisting of ten or more private companies that, in the view, are growing companies at the frontiers of their respective sectors and industries. The Fund operates as a single segment.